Literature DB >> 11587145

The pathology of dry eye.

C Baudouin1.   

Abstract

Homeostasis of the tear film involves delicate hormonal and neuronal regulatory mechanisms. The eye appears to be a target organ for sex hormones, particularly the androgens, as they modulate the immune system and trophic functions of the lacrimal glands and the functioning of the meibomian glands. The cornea, lacrimal glands, mucous cells, and meibomian glands are all richly innervated, indicating the importance of nervous regulation in their function. Parasympathetic, sympathetic, and sensory innervation play complex stimulatory or inhibitory roles, and neuronal pathways interact via complex surface results cascades. Abnormalities at any point in these pathways can cause overall dysregulation of lacrimal function. Whatever the initial causes of dry eye, chronic dryness of the ocular surface results in inflammatory reactions and gradual destruction of the lacrimal glands and conjunctival epithelium. Once dry eye disease has developed, inflammation is the key mechanism of ocular surface injury, as both the cause and consequence of cell damage. In practice, dry eye can be associated with Sjögren's syndrome, allergies, infection, blepharitis, and preservative-containing eye drops.

Entities:  

Mesh:

Year:  2001        PMID: 11587145     DOI: 10.1016/s0039-6257(00)00200-9

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  53 in total

1.  Current practice pattern for dry eye patients in South Korea: a multicenter study.

Authors:  Jong Suk Song; Joon Young Hyon; Doh Lee; Euisang Chung; Chulyoung Choi; Jeongbok Lee; Hyo Myung Kim
Journal:  Korean J Ophthalmol       Date:  2014-03-14

2.  A clinical study of the efficacy of topical corticosteroids on dry eye.

Authors:  Chong-qing Yang; Wen Sun; Yang-shun Gu
Journal:  J Zhejiang Univ Sci B       Date:  2006-08       Impact factor: 3.066

3.  A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva.

Authors:  Tanima Bose; Aihua Hou; Ryan Lee; Louis Tong; K George Chandy
Journal:  J Vis Exp       Date:  2017-07-05       Impact factor: 1.355

4.  Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.

Authors:  Françoise Brignole; Pierre-Jean Pisella; Bénédicte Dupas; Vincent Baeyens; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

Review 5.  [Chronic blepharitis. Pathogenesis, clinical features, and therapy].

Authors:  C Auw-Haedrich; T Reinhard
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

6.  The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Authors:  Koray Gumus; Dwight H Cavanagh
Journal:  Clin Ophthalmol       Date:  2009-06-02

7.  Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction.

Authors:  Sin Man Lam; Louis Tong; Xinrui Duan; U Rajendra Acharya; Jen Hong Tan; Andrea Petznick; Markus R Wenk; Guanghou Shui
Journal:  J Lipid Res       Date:  2014-07-03       Impact factor: 5.922

8.  Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.

Authors:  Sabrina Viau; Marie-Annick Maire; Bruno Pasquis; Stéphane Grégoire; Cynthia Fourgeux; Niyazi Acar; Lionel Bretillon; Catherine P Creuzot-Garcher; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-21       Impact factor: 3.117

9.  Analysis of the effects of preservative-free tafluprost on the tear proteome.

Authors:  Sebastian Funke; Sabine Beck; Katrin Lorenz; Marion Kotterer; Dominik Wolters; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

10.  Bilateral corneal perforation in familial amyloidotic polyneuropathy.

Authors:  André A Dosso; Elisabeth Rungger-Brändle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.